Dr. Sahil Bambroo

Dr Sahil Bambroo is a medical oncologist in Delhi with 15 years of experience specialising in solid tumour oncology, haematological malignancies, immunotherapy, targeted therapy, and molecular profiling of cancers, currently practising at Manipal Hospital, Dwarka, Delhi.

He completed his DM in Medical Oncology from Amrita Institute of Medical Sciences, Kochi, served as Assistant Professor of Medical Oncology and Haematology at the same institution, completed a clinical observership at Henry Ford Health System, Detroit, USA, and is an editorial board member of the International Journal of Molecular and Immuno-Oncology.

He consults in English, Hindi, Malayalam, and Kannada.

Area of Expertise

Breast and Gynaecological Oncology

Patients with breast cancer and gynaecological malignancies are managed by Dr Sahil Bambroo with evidence based medical oncology protocols including systemic and targeted therapies:

• Breast cancer chemotherapy and hormonal therapy
• HER2 targeted therapy
• Gynaecological cancer management
• Ovarian and cervical cancer treatment
• Neoadjuvant and adjuvant systemic therapy

Lung Cancer

Patients with non small cell and small cell lung cancers are evaluated with molecular profiling and managed with appropriate systemic treatment strategies:

• Lung cancer systemic therapy
• EGFR and ALK targeted therapy
• Immunotherapy for lung cancer
• Advanced lung cancer management
• Molecular guided treatment planning

Haematological Malignancies

Patients with blood cancers and lymphoid disorders are assessed and managed with chemotherapy, targeted therapy, and supportive care protocols:

• Leukaemia management
• Lymphoma treatment
• Multiple myeloma care
• Haematological disorder evaluation
• Bone marrow disease management

Gastrointestinal and Hepatobiliary Cancers

Patients with GI and hepatobiliary malignancies are managed with systemic oncology protocols including chemotherapy and targeted agents:

• Colorectal cancer systemic therapy
• Gastric and oesophageal cancer treatment
• Hepatocellular carcinoma management
• Pancreatic cancer treatment
• Biliary tract cancer care

Genitourinary and Prostate Cancers

Patients with prostate, kidney, and bladder cancers are evaluated and managed with hormonal, targeted, and immunotherapy based treatment plans:

• Prostate cancer systemic therapy
• Renal cell carcinoma targeted therapy
• Bladder cancer management
• Genitourinary cancer evaluation
• Hormonal therapy planning

Immunotherapy and Targeted Therapy

Patients with eligible cancer types are assessed for immunotherapy and molecularly targeted treatment with biomarker guided protocols:

• Immune checkpoint inhibitor therapy
• Molecularly targeted cancer therapy
• Biomarker and molecular profiling
• EGFR, BRAF, HER2 targeted treatment
• Immunotherapy toxicity management

Preventive and Community Oncology

Patients seeking cancer risk assessment and early detection support are guided with structured preventive oncology counselling:

• Cancer risk stratification
• Preventive oncology counselling
• Community cancer detection programmes
• Cancer awareness and outreach
• Daycare chemotherapy unit management

Credentials and Qualifications

• MBBS, Karnataka Institute of Medical Sciences, Hubli, Rajiv Gandhi University of Health Sciences (2011)
• MD General Medicine, Amrita Institute of Medical Sciences, Kochi (2016)
• DM Medical Oncology, Amrita Institute of Medical Sciences, Kochi (2019)
• Clinical Observer, Henry Ford Health System, Detroit, Michigan, USA (May 2018)
• Editorial Board Member, International Journal of Molecular and Immuno-Oncology
• Delhi Medical Council Registration No. 75935 (2016)
• Travancore Cochin Medical Council Registration No. 74646

Awards and Academic Recognition

• Observership, Henry Ford Health System, Detroit, Michigan, USA (2018)
• Second Prize in Quiz, ONCOLOGY 2018, Multidisciplinary Management of Common Cancers
• Second Prize in Poster, Analysis of EGFR 18, 19 and EGFR vIII Overexpression in GBM and its Prognostic Significance, ISNOCON 2018, AIIMS Delhi
• Aswath Ram Jaya Nazir Award for highest marks in Preventive and Social Medicine (2009)

Research and Publications

Dr Bambroo has authored research publications in national and international oncology journals and has mentored DM and DrNB trainees, medical residents, and allied health professionals:

• "Adherence to Antiemesis Guidelines in a Day Care Chemotherapy Unit: Experience from a Tertiary Care Centre," Indian Journal of Applied Research, Volume 9, Issue 12, December 2019
• "Patellar Metastasis in Renal Cell Carcinoma: A Rare Presentation." Bambroo S, Mohan T, Pavithran K. Indian Journal of Medical and Paediatric Oncology, December 2021
• DM Dissertation: Analysis of BRAF V600E Mutation in the Central Nervous System at a Tertiary Cancer Centre in India
• MD Dissertation: Association between HbA1c Levels and Iron Deficiency Anaemia in Non-Diabetic Individuals

Professional Memberships

• European Society of Medical Oncology (ESMO), Member
• European Society of Digestive Oncology (ESDO)
• American Society of Clinical Oncology (ASCO)
• Indian Society of Neuro-Oncology (ISNO)
• Association of Physicians of India (API), Kerala Chapter

Professional Experience

Current Hospital Affiliation

Dr Sahil Bambroo currently practises at:

• Manipal Hospital, Dwarka, Delhi, Consultant Medical Oncology

Previous Associations

• Max Super Speciality Hospital, Shalimar Bagh, Consultant Medical Oncology (2022)
• Kailash Hospital, Noida and Greater Noida, Consultant Medical Oncology (2020 to 2022)
• ESIC Hospital, Okhla, Delhi, Consultant (2022)
• Amrita Institute of Medical Sciences, Kochi, Assistant Professor of Medical Oncology and Haematology (2019 to 2020)
• Pushpawati Singhania Research Institute, Sheikh Sarai, Delhi, Senior Resident (2016)

Book an Appointment with Dr Sahil Bambroo, Medical Oncologist in Delhi

To check consultation availability and book an appointment with Dr Sahil Bambroo at Manipal Hospital, Dwarka, Delhi, visit HexaHealth for a smooth and priority booking experience.